InvesTrust Invests $1.82 Million in CVS Health Co. (NYSE:CVS)

InvesTrust bought a new position in CVS Health Co. (NYSE:CVS) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 40,815 shares of the pharmacy operator’s stock, valued at approximately $1,823,000.

A number of other large investors have also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the 3rd quarter valued at $25,000. Livelsberger Financial Advisory bought a new position in shares of CVS Health in the third quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the 3rd quarter worth about $31,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter valued at approximately $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new position in CVS Health in the 3rd quarter worth approximately $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS stock traded up $0.12 during trading hours on Wednesday, hitting $45.90. 7,476,451 shares of the company’s stock were exchanged, compared to its average volume of 11,352,654. The stock’s 50-day moving average is $52.40 and its 200-day moving average is $56.86. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $81.03. The stock has a market cap of $57.76 billion, a price-to-earnings ratio of 11.65, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter last year, the company posted $2.21 EPS. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, research analysts forecast that CVS Health Co. will post 5.32 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 5.80%. CVS Health’s payout ratio is 67.51%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Piper Sandler lowered their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. UBS Group raised their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. Finally, Mizuho cut their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.